2 More Significant Survival Benefit For Non-Small Cell Lung Cancer Patients Under 55 Years Of Age, Also Using Immunotherapy! Apr 17, 2025
3 Good Clinical Data For SRF388, An Innovative Lung Cancer Drug, With Patients Stable For Apr 15, 2025
4 Over 30% Of Tumours In Advanced Lung Cancer Patients In Remission With Frontier Drug Teliso-V In Combination With Troche! Apr 10, 2025
5 K-Drug Approved For Adjuvant Treatment Of Early-Stage Non-Small Cell Lung Cancer, Significantly Extending Cancer-Free Survival Of Patients! Apr 08, 2025
6 J. Enzyme Inhib. Med. Chem. | Protac Targeting Aimp2-Dx2: a New Therapy For Lung Cancer Apr 06, 2025
Read More Disease What Are The Causes Of Nasopharyngeal Carcinoma? What Are The Treatment Options For Nasopharyngeal Carcinoma? Apr 20, 2025
Read More Apparatus Another Cancer-Independent Targeted Drug Approved! Up To 84% Efficacy! Apr 08, 2025
Read More Apparatus Over 30% Of Tumours In Advanced Lung Cancer Patients In Remission With Frontier Drug Teliso-V In Combination With Troche! Apr 10, 2025
Read More Medical New Strategies For Cancer Vaccines: Transforming Cancer Cells So They Can Become Cancer-Fighters Is Not Far Away! Apr 01, 2025
Read More Apparatus The Frontier Drug INT230-6 Has Shown Promising Therapeutic Results In Soft Tissue Sarcoma! Apr 16, 2025
